[1] Anderson FH, Zeng L, Rock NR, et al. An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C. Hepatol Res, 2000, 18:63-71.
[2] Chang Y, Ryu S, Zhang Y, et al. A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. Plos One, 2012, 7: 37241.
[3] Ge PL, Du SD, Mao YL. Advances in preoperative assessment of liver function. Hepatobiliary Pancreat Dis Int, 2014, 13:361-370.
[4] Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
[5] Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31:864-871.
[6] Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33:464-470.
[7] Shen Y, Liu YM, Wang B, et al. External validation and comparison of six prognostic models in a prospective cohort of HBV-ACLF in China. Ann Hepatol, 2016, 15:236.
[8] Dutkowski P, Oberkofler CE, Béchir M, et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.Liver Trans, 2011, 17:674–684.
[9] Garciasaenzdesicilia M, Duvoor C, Altamirano J, et al. Corrigendum: A day-4 lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis. Am J Gastroenterol, 2017, 112:306-315.
[10] Papastergiou V, Burroughs AK, Tsochatzis EA. Prognosis and treatment of patients with acute alcoholic hepatitis. Expert Rev Gastroenterol Hepatol, 2014, 8:471-486.
[11] Fikatas P, Lee JE, Sauer IM, et al. APACHE III score is superior to King's College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure. Transplant Proc, 2013, 45:2295.
[12] Yokoyama Y, Nagino M. Benefit to Perform Indocyanine Green Clearance Test: Reply. World J Surg, 2017, 41:339-340.
[13] Au KP, Chan SC, Chok KS, et al. Child-Pugh parameters and platelet count as an alternative to ICG test for assessing liver function for major hepatectomy. HPB Surg, 2017:1-8.
[14] Wang W, Zhao Q, Hu A, et al. Application of Indocyanine Green (ICG) detection in evaluating early prognosis in patients with fatty liver disease after liver transplantation. Ann Transplant, 2017, 22:208-214.
[15] Hiwatashi K, Ueno S, Sakoda M, et al. The evaluation of liver function and surgical influence by ICGR15 after chemotherapy for colorectal liver metastases. J Cancer, 2016, 7:595.
[16] Sharma P, Bansal R, Matin A, et al. Role of transient elastography (Fibroscan) in differentiating severe acute hepatitis and acute on chronic liver failure. J Clin Exp Hepatol, 2015, 5:303-309.
[17] Afdhal NH, Bacon BR, Patel K, et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol, 2015, 13:772.
[18] Wong LH, Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep, 2013, 1:19-26.
[19] Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg, 2009, 250:540-548.
[20] Feng LM, Lei SJ, Zeng X, et al. The evaluation of the non-invasive MSCT-based indices for the diagnosis and prognosis prediction of liver cirrhosis. J Dig Dis, 2017, 18:472-479.
[21] 石桥, 谢婷婷, 袁知东, 等. 双能量CT碘定量参数评估肝硬化患者肝脏血流灌注重分布及肝功能的临床价值. 放射学实践, 2017,32:734-738.
[22] Fu Y, Peng HJ, Zhang X, et al. Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis. Eur Radiol, 2016, 26:1-9.
[23] Chang CC, Huang HC, Liu KL, et al. Clinical feasibility of Gd-EOB-DTPA-enhanced MR imaging for assessing liver function: validation with ICG tests and parenchymal cell volume. Clin Imaging, 2016, 40:797.
[24] Xie S, Sun Y, Wang L, et al. Assessment of liver function and liver fibrosis with dynamic Gd-EOB-DTPA-enhanced MRI. Acad Radiol, 2015, 22:460-466.
[25] Naokazu C , Kei Y , Shigeto O , et al. The diagnostic value of 99m-Tc GSA scintigraphy for liver function and remnant liver volume in hepatic surgery: a retrospective observational cohort study in 27 patients. Patient Saf Surg, 2018, 12:15. |
